Medtronic has launched its Mazor X Stealth robotic-assisted spinal surgical platform in the U.S., touting its recent use in its first commercial procedures. The first uses of the system took place at Louisville, Ky.’s Norton Healthcare and Reston, Va.’s Reston Hospital Center, the Fridley, Minn.-based medtech giant said. “The marriage of robotics and navigation represents the…
Mazor Robotics acquired by Medtronic in $1.7B deal
Medtronic has closed the $1.7 billion acquisition of Mazor Robotics and its robot-assisted surgery platform. Medtronic capped the buyout with the announcement that its first jointly produced product won an FDA nod. Last month Caesarea, Israel-based Mazor said its shareholders voted to approve the $58.50-per-ADR-share deal with the world’s largest medical device maker, which has…
Mazor Robotics bought by Medtronic for $1.6B
Medtronic has owned since 2016 a $300 million stake (about 11%) in Mazor, which is widely regarded as a leader in robot-assisted spine surgery. By 2022, the global spinal surgical robotics market is expected to reach $2.77 billion. Mazor makes the Mazor X guidance system and the Renaissance robot-assisted spine surgery platform. Medtronic became the…
Mazor X surgery platform from Mazor Robotics wins CE Mark
Mazor Robotics (NSDQ:MZOR) said today that it won CE Mark approval in the European Union for its Mazor X robot-assisted surgery platform, setting the stage for strategic backer Medtronic (NYSE:MDT) to put the device on the European market. “Receipt of the CE Mark is an important step in our plan to expand the patient, surgeon and hospital benefits…
Medtronic, Mazor Robotics close $40m round
Mazor Robotics (NSDQ:MZOR) said today that closed the third, $40 million tranche of a deal with Medtronic (NYSE:MDT), which is due to take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million, 10.6% stake in…
Medtronic puts another $40m into Mazor Robotics
Mazor Robotics (NSDQ:MZOR) said today that it’s accelerating a deal with Medtronic (NYSE:MDT), which is due to put another $40 million into Mazor and take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million and…
Mazor Robotics slides on Q1 prelims
Share prices for Mazor Robotics (NSDQ:MZOR) slid today despite preliminary 1st-quarter sales numbers that beat expectations on Wall Street. The Caesarea, Israel-based robot-assisted surgery device maker said it expects to post sales of $11.5 million for the 3 months ended March 31, ahead of The Street’s $11.2 million forecast and up 79.7% compared with Q1 2016. Investors…
9 cardiology breakthroughs you need to know
Cardiology breakthroughs couldn’t come soon enough because heart disease is the No. 1 killer of men and women in the U.S. About 610,000 Americans die of heart disease per year, and an additional 735,000 Americans suffer from a heart attack. The statistics terrify. About 610,000 Americans die of heart disease per year, and an additional…
Analyst: There’s a ‘mismatch’ between expectations and reality for Stryker’s Mako platform
A 51-physician Barclays survey of U.S. hip and knee surgeons today prompted analyst Matthew Taylor to question investors’ expectations for Stryker‘s (NYSE:SYK) Mako robot-assisted surgery platform. Some 22% of the docs surveyed reported using the Mako system, most for partial knee replacement procedures, with 25.5% saying they would use it more in the future, Taylor…